SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 1, 1997
AMERICAN BIOGENETIC SCIENCES, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
0-19041 11-2655906
(Commission File Number) (IRS Employer Identification No.)
1375 Akron Street, Copiague, New York 11726
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 516-789-2600
Not Applicable
(Former name or former address, if changed since last report)
Item 5.Other Events
On October 1, 1997, Paul E. Gargan, Ph.D., submitted
letters indicating his intention to resign his position as
President, Chief Scientific Officer and a Director of the Company
to pursue another position. On the same date, the Company
terminated Dr. Gargan's employment under the terms of the May 10,
1996 Employment Agreement between the Company and Dr. Gargan.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
AMERICAN BIOGENETIC SCIENCES, INC.
(Registrant)
Dated: October 20, 1997 By: /s/ Josef C. Schoell
-------------------------
Josef C. Schoell
Vice President Finance